Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152,309,909
-
Number of holders
-
525
-
Total 13F shares, excl. options
-
155,453,274
-
Shares change
-
+2,964,299
-
Total reported value, excl. options
-
$11,990,770,023
-
Value change
-
+$252,157,462
-
Put/Call ratio
-
50.91%
-
Number of buys
-
260
-
Number of sells
-
-244
-
Price
-
$77.16
Significant Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q4 2023
621 filings reported holding TECH - BIO-TECHNE Corp - COMMON STOCK as of Q4 2023.
BIO-TECHNE Corp - COMMON STOCK (TECH) has 525 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 155,453,274 shares
.
Largest 10 shareholders include VANGUARD GROUP INC (18,228,210 shares), BlackRock Inc. (18,133,912 shares), STATE STREET CORP (6,328,129 shares), BAMCO INC /NY/ (5,352,006 shares), Select Equity Group, L.P. (4,559,173 shares), MORGAN STANLEY (4,088,095 shares), GEODE CAPITAL MANAGEMENT, LLC (3,721,727 shares), NEUBERGER BERMAN GROUP LLC (3,692,675 shares), BROWN CAPITAL MANAGEMENT LLC (3,550,990 shares), and DF DENT & CO INC (3,241,172 shares).
This table shows the top 525 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.